An interventional study of Dexamethasone and Mepivicaine in Anesthesia, sponsored by University Health Network, Toronto. Completed at 1 site in Canada. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2010-01-26.
Sponsored by University Health Network, Toronto · Not applicable, Interventional, and Treatment
Patients undergoing surgery of the hand often are treated with a nerve block in the shoulder/neck area that provides anesthesia/numbing during surgery. Nerve blocks usually last for a few hours after surgery and provide pain relief for this period. It may be possible to extend the duration of anesthesia by using a steroid, which has anti-inflammtory properties. This study will compare the duration of the nerve block when dexamethasone (steroid) is added to the anesthetic injected around the nerve.
University Health Network, Toronto is the lead sponsor of 1,411 studies on the registry; 292 are open to participants now.
Of its 17 completed or terminated interventional studies of FDA-regulated products, 3 (18%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Dexamethasone 8mg added to routine local anesthetic during brachial plexus blockade.
Drug: Dexamethasone · Drug: Mepivicaine
Routine anesthetic solution (30 cc 1.5% mepivicaine) used during brachial plexus blockade.
Drug: Mepivicaine
Dexamethasone 8 milligrams (liquid) will be added to standard anesthetic solution administered during routine brachial plexus nerve blockade.
Standard anesthetic solution administered during routine brachial plexus nerve blockade.
Duration of anesthesia
Time frame: hourly for first 24 hours; daily until discharge
Requirements for pain medications; complications
Time frame: up to 3 months
This study is completed, as verified in Jan 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Health Network, Toronto